WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹984 Cr | ₹423 Cr | ₹-718 Cr | ₹-1,521 Cr | ₹-762 Cr |
What is the latest Net Current Assets ratio of WOCKHARDT ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹984 Cr |
| Mar2025 | ₹423 Cr |
| Mar2024 | ₹-718 Cr |
| Mar2023 | ₹-1,521 Cr |
| Mar2022 | ₹-762 Cr |
How is Net Current Assets of WOCKHARDT Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹984 Cr | 132.62 | |
| Mar2025 | ₹423 Cr | Positive | |
| Mar2024 | ₹-718 Cr | Negative | |
| Mar2023 | ₹-1,521 Cr | Negative | |
| Mar2022 | ₹-762 Cr | - | |
Compare Net Current Assets of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹30,312.8 Cr | -1.5% | -5% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -1.5% |
-5% |
4.4% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses